Jennifer Minai-Azary

Chief Financial Officer and TreasureratContext Therapeutics· In proxies 2022–2025

Pay in FY2025+24% from the year before · Context Therapeutics stock +40.0% the same year

Jennifer Minai-Azary was paid $866.1K in FY2025 (Dec), up 24%. Context Therapeutics stock rose 40.0% that year.

Pay$100 in the stock at the end of FY21 → $55

Pay is from the Summary Compensation Table of each Context Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

CNTX
Context TherapeuticsPublic company · 4 yr
- Chief Financial Officer and Treasurer2022 – Present · 4 yrStock in role -93%

Roles come from the proxy statements of each company.

Activity

Pay
Context Therapeutics CFO pay rose 24% to $866.1K. The stock rose 40% in FY2025 (Dec).
DEF 14AApr 28, 2026
Pay
Context Therapeutics CFO pay rose 15% to $699.0K. The stock fell 7% in FY2024 (Dec).
DEF 14AApr 15, 2025
Pay
Context Therapeutics CFO pay fell 11% to $606.7K. The stock rose 73% in FY2023 (Dec).
DEF 14AApr 26, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?